Clause 14
;

14

Clauses 6 and 18 may also be relevant.

14.1

(7.3) A comparison is only permitted in promotional material if:

• it is not misleading

• medicines or services for the same needs or intended for the same purpose are compared

• one or more material, relevant, substantiable and representative features are compared

• no confusion is created between the medicine advertised and that of a competitor or between the advertiser’s trademarks, brand names, other distinguishing marks and those of a competitor

• the trademarks, brand names, other distinguishing marks, medicines, services, activities or circumstances of a competitor are not discredited or denigrated

• no unfair advantage is taken of the reputation of a trademark, brand name or other distinguishing marks of a competitor

• medicines or services are not presented as imitations or replicas of goods or services bearing a competitor’s trademark or brand name.

most recent cases See all Applicable Code year
Applicable Code year

Please check the date of the Code that applies to the Case that you are looking at. The date of the complaint may vary from the activity/material alleged to have been in breach.

AUTH/3719/12/22 - Chiesi/Director v GSK Breach: 5.1, 6.1, 6.2, 6.3, 14.1, 14.4 No breach: 2, 3.3, 5.1, 6.1, 6.6 Applicable Code: 2021 Received: 19 December 2022 Completed: 14 March 2024 AUTH/3699/10/22 - AstraZeneca v GSK Breach: 5.1, 6.1, 14.1 No breach: 2, 3.3, 6.1, 6.6 Applicable Code: 2021 Received: 18 October 2022 Completed: 18 December 2023 AUTH/3715/11/2022 - Complainant v GSK Breach: 5.1, 6.1, 6.2, 14.1 No breach: 2, 5.1, 6.6 Applicable Code: 2021 Received: 28 November 2022 Completed: 18 December 2023 AUTH/3768/5/23 - Health professional v Sandoz Breach: 3.1, 5.1, 6.2 No breach: 2, 3.1, 6.1, 6.3, 11.1, 14.1, 14.4 Applicable Code: 2021 Received: 11 May 2023 Completed: 23 February 2024 AUTH/3624/3/22 - Complainant v Pacira BioScience Breach: 5.1, 6.1, 6.2, 11.2, 14.4 No breach: 6.1, 6.4, 11.2, 14.1, 14.4, 17.9 Applicable Code: 2021 Received: 16 March 2022 Completed: 23 March 2023 AUTH/3592/12/21 - Bayer v Janssen No breach: 2, 5.1, 6.1, 6.2, 6.3, 6.4, 6.6, 11.2, 14.1 Applicable Code: 2021 Received: 17 December 2021 Completed: 03 March 2023 AUTH/3579/11/21 - Health professional v Novartis Breach: 5.1, 6.2, 6.1, 14.4, 26.1, 26.2 No breach: 2, 5.2, 5.5, 9.1, 9.3, 14.1, 14.2, 18.1 Applicable Code: 2021 Received: 08 November 2021 Completed: 09 November 2022 AUTH/3571/10/21 - Complainant v Merck Serono No breach: 2, 5.1, 6.1, 6.2, 11.2, 14.1 Applicable Code: 2021 Received: 22 October 2021 Completed: 27 July 2022 AUTH/3541/7/21 - A health professional v Roche Breach: 6.1, 6.2, 12.3 No breach: 2, 5.1, 6.1, 6.2, 6.5, 11.2, 14.1 Applicable Code: 2021 Received: 15 July 2021 Completed: 27 May 2022

14.2

(7.6) When promotional material refers to published studies, clear references must be given.

most recent cases See all Applicable Code year
Applicable Code year

Please check the date of the Code that applies to the Case that you are looking at. The date of the complaint may vary from the activity/material alleged to have been in breach.

14.3

(7.7) When promotional material refers to data on file, the relevant part of that data must be provided as soon as possible, and certainly within ten working days, in response to a request from a health professional or other relevant decision maker.

14.4

(7.10) Promotion must encourage the rational use of a medicine by presenting it objectively and without exaggerating its properties. Exaggerated or all-embracing claims must not be made and superlatives must not be used except for those limited circumstances where they relate to a clear fact about a medicine. Claims should not imply that a medicine or an active ingredient has some special merit, quality or property unless this can be substantiated.

most recent cases See all Applicable Code year
Applicable Code year

Please check the date of the Code that applies to the Case that you are looking at. The date of the complaint may vary from the activity/material alleged to have been in breach.

AUTH/3747/2/23 - Anonymous complainant v Otsuka UK Breach: 3.1, 5.1, 6.1, 9.1, 14.4 Applicable Code: 2021 Received: 28 February 2023 Completed: 04 June 2024 AUTH/3719/12/22 - Chiesi/Director v GSK Breach: 5.1, 6.1, 6.2, 6.3, 14.1, 14.4 No breach: 2, 3.3, 5.1, 6.1, 6.6 Applicable Code: 2021 Received: 19 December 2022 Completed: 14 March 2024 AUTH/3709/11/22 - Health professional v AstraZeneca Breach: 5.1, 6.1, 6.2, 14.4 No breach: 11.2 Applicable Code: 2021 Received: 16 November 2022 Completed: 20 October 2023 AUTH/3635/4/22 - Complainant v Novartis Breach: 2, 5.1, 6.1, 6.2, 14.4 No breach: 2, 5.1, 6.1, 6.2, 6.5, 14.4 Applicable Code: 2021 Received: 18 April 2022 Completed: 31 May 2023 AUTH/3618/3/22 - Complainant v AstraZeneca Breach: 2, 5.1, 6.1, 6.2, 11.2, 14.4 No breach: 6.2, 17.9 Applicable Code: 2021 Received: 11 March 2022 Completed: 03 April 2023 AUTH/3624/3/22 - Complainant v Pacira BioScience Breach: 5.1, 6.1, 6.2, 11.2, 14.4 No breach: 6.1, 6.4, 11.2, 14.1, 14.4, 17.9 Applicable Code: 2021 Received: 16 March 2022 Completed: 23 March 2023 AUTH/3579/11/21 - Health professional v Novartis Breach: 5.1, 6.2, 6.1, 14.4, 26.1, 26.2 No breach: 2, 5.2, 5.5, 9.1, 9.3, 14.1, 14.2, 18.1 Applicable Code: 2021 Received: 08 November 2021 Completed: 09 November 2022 AUTH/3768/5/23 - Health professional v Sandoz Breach: 3.1, 5.1, 6.2 No breach: 2, 3.1, 6.1, 6.3, 11.1, 14.1, 14.4 Applicable Code: 2021 Received: 11 May 2023 Completed: 23 February 2024 AUTH/3752/3/23 - PMCPA Director/Media v Novo Nordisk No breach: 2, 5.1, 6.1, 14.4, 19.1, 23.2, 24.2, 24.3, 27.1, 27.2, 27.5 Applicable Code: 2021 Received: 13 March 2023 Completed: 01 November 2023 AUTH/3668/6/22 - Complainant v Galapagos Breach: 6.1 No breach: 6.1, 6.2, 14.4 Applicable Code: 2021 Received: 29 June 2022 Completed: 03 July 2023 AUTH/3670/6/22 - Health Professional v Novartis Breach: 5.1, 12.9 No breach: 2, 5.1, 6.1, 6.2, 11.2, 14.4 Applicable Code: 2021 Received: 30 June 2022 Completed: 03 July 2023 AUTH/3601/1/22 - Complainant v Boehringer No breach: 14.4 Applicable Code: 2021 Received: 20 January 2022 Completed: 20 February 2023 AUTH/3591/12/21 - A complaint on behalf of UsForThem v Pfizer Breach: 6.1, 6.2, 26.2 No breach: 2, 3.1, 3.3, 5.1, 6.1, 6.2, 11.3, 14.4, 26.1, 26.2, 26.4 Applicable Code: 2021 Received: 11 December 2021 Completed: 06 December 2022 AUTH/3552/8/21 - Health professional v Roche Breach: 5.2, 8.1, 12.6, 12.9 No breach: 2, 5.1, 5.2, 6.1, 6.2, 14.4 Applicable Code: 2021 Received: 05 August 2021 Completed: 27 May 2022 AUTH/3563/9/21 and Case AUTH/3564/9/21 - Complainant v Bristol-Myers Squibb and Pfizer Breach: 12.9 No breach: 5.1, 6.1, 14.4 Applicable Code: 2021 Received: 29 September 2021 Completed: 26 April 2022

14.5

(6.2) None of the individual screens or pages etc of a multi screen/page advertisement must be false or misleading when read in isolation.

most recent cases See all Applicable Code year
Applicable Code year

Please check the date of the Code that applies to the Case that you are looking at. The date of the complaint may vary from the activity/material alleged to have been in breach.